United States Pneumococcal Vaccine Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Pneumococcal Vaccine Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by End User
1.3 United States Pneumococcal Vaccine Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Pneumococcal Vaccine Overall Market Size
2.1 United States Pneumococcal Vaccine Market Size: 2021 VS 2027
2.2 United States Pneumococcal Vaccine Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Pneumococcal Vaccine Sales: 2016-2027
3 Company Landscape
3.1 Top Pneumococcal Vaccine Players in United States Market
3.2 Top United States Pneumococcal Vaccine Companies Ranked by Revenue
3.3 United States Pneumococcal Vaccine Revenue by Companies
3.4 United States Pneumococcal Vaccine Sales by Companies
3.5 United States Pneumococcal Vaccine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Pneumococcal Vaccine Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Pneumococcal Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pneumococcal Vaccine Players in United States Market
3.8.1 List of Tier 1 Pneumococcal Vaccine Companies in United States
3.8.2 List of Tier 2 and Tier 3 Pneumococcal Vaccine Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Pneumococcal Vaccine Market Size Markets, 2021 & 2027
4.1.2 PPSV 23
4.1.3 PCV 7/13
4.1.4 PCV 10
4.2 By Type - United States Pneumococcal Vaccine Revenue & Forecasts
4.2.1 By Type - United States Pneumococcal Vaccine Revenue, 2016-2021
4.2.2 By Type - United States Pneumococcal Vaccine Revenue, 2022-2027
4.2.3 By Type - United States Pneumococcal Vaccine Revenue Market Share, 2016-2027
4.3 By Type - United States Pneumococcal Vaccine Sales & Forecasts
4.3.1 By Type - United States Pneumococcal Vaccine Sales, 2016-2021
4.3.2 By Type - United States Pneumococcal Vaccine Sales, 2022-2027
4.3.3 By Type - United States Pneumococcal Vaccine Sales Market Share, 2016-2027
4.4 By Type - United States Pneumococcal Vaccine Price (Manufacturers Selling Prices), 2016-2027
5 Sights by End User
5.1 Overview
5.1.1 By End User - United States Pneumococcal Vaccine Market Size, 2021 & 2027
5.1.2 Child
5.1.3 Adult
5.2 By End User - United States Pneumococcal Vaccine Revenue & Forecasts
5.2.1 By End User - United States Pneumococcal Vaccine Revenue, 2016-2021
5.2.2 By End User - United States Pneumococcal Vaccine Revenue, 2022-2027
5.2.3 By End User - United States Pneumococcal Vaccine Revenue Market Share, 2016-2027
5.3 By End User - United States Pneumococcal Vaccine Sales & Forecasts
5.3.1 By End User - United States Pneumococcal Vaccine Sales, 2016-2021
5.3.2 By End User - United States Pneumococcal Vaccine Sales, 2022-2027
5.3.3 By End User - United States Pneumococcal Vaccine Sales Market Share, 2016-2027
5.4 By End User - United States Pneumococcal Vaccine Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Overview
6.1.3 Pfizer Pneumococcal Vaccine Sales and Revenue in United States Market (2016-2021)
6.1.4 Pfizer Pneumococcal Vaccine Product Description
6.1.5 Pfizer Recent Developments
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Overview
6.2.3 GSK Pneumococcal Vaccine Sales and Revenue in United States Market (2016-2021)
6.2.4 GSK Pneumococcal Vaccine Product Description
6.2.5 GSK Recent Developments
6.3 MSD
6.3.1 MSD Corporation Information
6.3.2 MSD Overview
6.3.3 MSD Pneumococcal Vaccine Sales and Revenue in United States Market (2016-2021)
6.3.4 MSD Pneumococcal Vaccine Product Description
6.3.5 MSD Recent Developments
6.4 Sanofipasteur
6.4.1 Sanofipasteur Corporation Information
6.4.2 Sanofipasteur Overview
6.4.3 Sanofipasteur Pneumococcal Vaccine Sales and Revenue in United States Market (2016-2021)
6.4.4 Sanofipasteur Pneumococcal Vaccine Product Description
6.4.5 Sanofipasteur Recent Developments
6.5 CDIBP
6.5.1 CDIBP Corporation Information
6.5.2 CDIBP Overview
6.5.3 CDIBP Pneumococcal Vaccine Sales and Revenue in United States Market (2016-2021)
6.5.4 CDIBP Pneumococcal Vaccine Product Description
6.5.5 CDIBP Recent Developments
7 United States Pneumococcal Vaccine Production Capacity, Analysis
7.1 United States Pneumococcal Vaccine Production Capacity, 2016-2027
7.2 Pneumococcal Vaccine Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Pneumococcal Vaccine Supply Chain Analysis
9.1 Pneumococcal Vaccine Industry Value Chain
9.2 Pneumococcal Vaccine Upstream Market
9.3 Pneumococcal Vaccine Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Pneumococcal Vaccine Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Pneumococcal Vaccine in United States Market
Table 2. Top Pneumococcal Vaccine Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Pneumococcal Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Pneumococcal Vaccine Revenue Share by Companies, 2016-2021
Table 5. United States Pneumococcal Vaccine Sales by Companies, (K Doses), 2016-2021
Table 6. United States Pneumococcal Vaccine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Pneumococcal Vaccine Price (2016-2021) & (USD/Dose)
Table 8. Manufacturers Pneumococcal Vaccine Product Type
Table 9. List of Tier 1 Pneumococcal Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Pneumococcal Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of PPSV 23
Table 12. Major Manufacturers of PCV 7/13
Table 13. By Type - United States Pneumococcal Vaccine Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Pneumococcal Vaccine Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Pneumococcal Vaccine Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Pneumococcal Vaccine Sales (K Doses), 2016-2021
Table 17. By Type - United States Pneumococcal Vaccine Sales (K Doses), 2022-2027
Table 18. By End User - United States Pneumococcal Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 19. By End User - United States Pneumococcal Vaccine Revenue (US$, Mn), 2016-2021
Table 20. By End User - United States Pneumococcal Vaccine Revenue (US$, Mn), 2022-2027
Table 21. By End User - United States Pneumococcal Vaccine Sales (K Doses), 2016-2021
Table 22. By End User - United States Pneumococcal Vaccine Sales (K Doses), 2022-2027
Table 23. Pfizer Corporation Information
Table 24. Pfizer Description and Major Businesses
Table 25. Pfizer Pneumococcal Vaccine Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 26. Pfizer Pneumococcal Vaccine Product
Table 27. Pfizer Recent Developments
Table 28. GSK Corporation Information
Table 29. GSK Description and Major Businesses
Table 30. GSK Pneumococcal Vaccine Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 31. GSK Pneumococcal Vaccine Product
Table 32. GSK Recent Developments
Table 33. MSD Corporation Information
Table 34. MSD Description and Major Businesses
Table 35. MSD Pneumococcal Vaccine Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 36. MSD Pneumococcal Vaccine Product
Table 37. MSD Recent Developments
Table 38. Sanofipasteur Corporation Information
Table 39. Sanofipasteur Description and Major Businesses
Table 40. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 41. Sanofipasteur Pneumococcal Vaccine Product
Table 42. Sanofipasteur Recent Developments
Table 43. CDIBP Corporation Information
Table 44. CDIBP Description and Major Businesses
Table 45. CDIBP Pneumococcal Vaccine Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 46. CDIBP Pneumococcal Vaccine Product
Table 47. CDIBP Recent Developments
Table 48. Pneumococcal Vaccine Production Capacity (K Doses) of Key Manufacturers in United States Market, 2019-2021 (K Doses)
Table 49. United States Pneumococcal Vaccine Capacity Market Share of Key Manufacturers, 2019-2021
Table 50. Pneumococcal Vaccine Market Opportunities & Trends in United States Market
Table 51. Pneumococcal Vaccine Market Drivers in United States Market
Table 52. Pneumococcal Vaccine Market Restraints in United States Market
Table 53. Pneumococcal Vaccine Raw Materials
Table 54. Pneumococcal Vaccine Raw Materials Suppliers in United States Market
Table 55. Typical Pneumococcal Vaccine Downstream
Table 56. Pneumococcal Vaccine Downstream Clients in United States Market
Table 57. Pneumococcal Vaccine Distributors and Sales Agents in United States Market
List of FiguresFigure 1. Pneumococcal Vaccine Product Picture
Figure 2. Pneumococcal Vaccine Segment by Type
Figure 3. Pneumococcal Vaccine Segment by End User
Figure 4. United States Pneumococcal Vaccine Market Overview: 2020
Figure 5. United States Pneumococcal Vaccine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Pneumococcal Vaccine Revenue, 2016-2027 (US$, Mn)
Figure 7. Pneumococcal Vaccine Sales in United States Market: 2016-2027 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Pneumococcal Vaccine Revenue in 2020
Figure 9. PPSV 23 Product Picture
Figure 10. PCV 7/13 Product Picture
Figure 11. PCV 10 Product Picture
Figure 12. By Type - United States Pneumococcal Vaccine Sales Market Share, 2016-2027
Figure 13. By Type - United States Pneumococcal Vaccine Revenue Market Share, 2016-2027
Figure 14. By Type - United States Pneumococcal Vaccine Price (USD/Dose), 2016-2027
Figure 15. Child
Figure 16. Adult
Figure 17. By End User - United States Pneumococcal Vaccine Sales Market Share, 2016-2027
Figure 18. By End User - United States Pneumococcal Vaccine Revenue Market Share, 2016-2027
Figure 19. By End User - United States Pneumococcal Vaccine Price (USD/Dose), 2016-2027
Figure 20. Pfizer Pneumococcal Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. GSK Pneumococcal Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. MSD Pneumococcal Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Sanofipasteur Pneumococcal Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. CDIBP Pneumococcal Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. United States Pneumococcal Vaccine Production Capacity (K Doses), 2016-2027
Figure 26. Pneumococcal Vaccine Industry Value Chain
Figure 27. Marketing Channels